ANTIPHOSPHOLIPID SYNDROME
Clinical trials for ANTIPHOSPHOLIPID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood clot drug trial for rare autoimmune disease pulled before start
Disease control TerminatedThis study aimed to test if crovalimab, added to standard blood thinners, could prevent dangerous blood clots in people with antiphospholipid syndrome (APS). APS is an autoimmune disease that increases clot risk. The trial was withdrawn before enrolling any participants, so no re…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New MRI study seeks hidden stroke causes in rare blood disorder
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at why people with antiphospholipid syndrome (APS) — a condition that raises blood clot risk — may have narrowed brain arteries. Researchers will use advanced MRI scans on 60 APS patients to check for artery narrowing and plaque buildup. The goal is to better und…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Rare disease pregnancy study pulled before it began
Knowledge-focused TerminatedThis study was designed to track pregnancies in women with rare autoimmune and systemic diseases to understand complications and improve care. It planned to enroll women with conditions like lupus, rheumatoid arthritis, and scleroderma. However, the study was withdrawn before any…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC